Francisco, Lizlie Jane M.
HRN: 07-37-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2024
CEFUROXIME 750MG (VIAL)
10/24/2024
10/30/2024
IVT
750mg
Q8
Pyelonephritis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes